Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|24|4|379-386

ISSN： 0253-5068

Source： Blood Purification, Vol.24, Iss.4, 2006-08, pp. : 379-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with Sevelamer Decreases Bicarbonate Levels in Hemodialysis Patients

By  

Nephron, Vol. 92, Iss. 2, 2002-09 ,pp. : 499-500

Karger

Access to resources Recommend Favorite

Correlations of Sialic Acid with Markers of Inflammation, Atherosclerosis and Cardiovascular Events in Hemodialysis Patients

By  

Blood Purification, Vol. 26, Iss. 3, 2008-04 ,pp. : 261-266

Karger

Access to resources Recommend Favorite

Reduction of the Homocysteine Plasma Concentration by Intravenously Administered Folinic Acid and Vitamin B12 in Uraemic Patients on Maintenance Haemodialysis

By  

American Journal of Nephrology, Vol. 21, Iss. 4, 2001-08 ,pp. : 294-299

Karger

Access to resources Recommend Favorite

Associations among Darbepoetin-α, CD34+ Cells and Cardiovascular Disease Events in Patients on Hemodialysis

By  

Nephron Extra, Vol. 2, Iss. 1, 2012-09 ,pp. : 233-246

Karger

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease Proven by Transient Elastography in Hemodialysis Patients: Is It a New Risk Factor for Adverse Cardiovascular Events?

By  

Blood Purification, Vol. 37, Iss. 4, 2014-07 ,pp. : 259-265

Karger

Access to resources Recommend Favorite